Market Overview

Benzinga's Top Upgrades

Related ABT
Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Revenue
5 Companies That Have Moved Overseas For Lower Taxes
Buyback Mania Inflates 2Q Earnings Growth (Fox Business)
Related PCLN
Momentum Stocks Showing Weakness
Trade Options With Caution; The Bulls Are Not Convincing
Tech M&A Surges in 2Q (Fox Business)

Analysts at Goldman Sachs upgraded Abbott Laboratories (NYSE: ABT) from “neutral” to “buy.” The target price for Abbott Laboratories has been raised from $38 to $44. Abbott's stock closed at $36.59 on Friday.

Deutsche Bank upgraded priceline.com (NASDAQ: PCLN) from “hold” to “buy.” The target price for priceline.com has been raised from $715 to $900. priceline.com's shares closed at $813.66 on Friday.

Analysts at Maxim Group upgraded J.C. Penney Company (NYSE: JCP) from “hold” to “buy.” The target price for J.C. Penney has been raised from $16.50 to $27. J.C. Penney's shares closed at $18.01 on Friday.

Morgan Stanley upgraded E-Commerce China Dangdang (NYSE: DANG) from “equal-weight” to “overweight.” The target price for E-Commerce China Dangdang has been raised from $5 to $6.50. E-Commerce China Dangdang's shares closed at $5.71 on Friday.

Latest Ratings for ABT

DateFirmActionFromTo
Jul 2014BarclaysMaintainsEqual-weight
Jul 2014Raymond JamesMaintainsOutperform
Jul 2014JefferiesMaintainsBuy

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ABT + DANG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters